RPAM
Rhenman & Partners Asset Management’s Janux Therapeutics JANX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Sell |
55,127
-86,500
| -61% | -$2M | 0.16% | 83 |
|
|
2025
Q1 | $3.82M | Sell |
141,627
-28,373
| -17% | -$766K | 0.44% | 52 |
|
|
2024
Q4 | $9.1M | Buy |
170,000
+63,153
| +59% | +$3.38M | 0.94% | 41 |
|
|
2024
Q3 | $4.85M | Hold |
106,847
| – | – | 0.39% | 66 |
|
|
2024
Q2 | $4.48M | Buy |
106,847
+2,347
| +2% | +$98.3K | 0.43% | 58 |
|
|
2024
Q1 | $3.93M | Buy |
+104,500
| New | +$3.93M | 0.37% | 58 |
|